Market Status
Exosomes are small (30–150 nm) vesicles containing sophisticated RNA and protein transporters.
It is understood to be secreted specifically for the purpose of intercellular signal transduction, and interest is rapidly increasing for the purpose of understanding methods to be used for functional studies and the development of minimally invasive diagnostic methods.
One of the extracellular vesicles secreted by living cells. The endoplasmic reticulum is a sac-like substance and can be understood as a carrier that transmits signals (information) between cells. Exosomes secreted by living cells are contained in nano-endoplasmic reticulum because the particles are in nanometer units. Exosomes, which have been regarded only as 'cell debris', contain cellular genetic material, bio-factor proteins, and active substances for stem cell functions, and are in the spotlight as a new bio-food.
In fact, the exosome treatment market is expected to show a high growth rate of 38.3% annually from $45.58 million in 2019. Stem cell therapeutics can cause differences in efficacy due to tumors, unnecessary differentiation, and cell engraftment, but exosome therapeutics can compensate for these shortcomings.
It means cell control technology is possible!! As a result, a significant portion of the stem cell market is expected to be replaced by exosomes.
It can be used in a variety of ways as anti-inflammatory drugs and various beauty treatment products. Currently, the rapid recovery and positive prognosis after surgical pain, plastic surgery and skin treatment have been proven.
As a leading pioneer in the bio industry, BloomCell Korea is expected to present a lot of research and objectives in this field..
Korea Bloom Cell's large sequential planning roadmap
1st year
2nd year
3rd year
in-depth business planning and portfolio constructionMove-in to the Industrial Support Center (industrial-academic incubator) and organize a researcher and management planning teamVenture certification, GMP clinical laboratory and basic manufacturing facility establishmentEstablishment of basic overseas marketing work in China, Russia, North America, and EuropeTechnology development and clinical research, treatment algorithm development
GMP cleanroom certified manufacturing and manufacturing facilities completedDevelopment and production of 3 or more productsExpansion of domestic and overseas marketing using online, SNS, and YouTubeProduct licensing in progress / Establishment of foundation for biopharmaceutical product development > Profit creationEstablishment of big data utilization plan based on clinical trial results
product diversification planIncrease production system for mass productionPromoting an increase in yield / Maximizing profit creation
